Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov-Dec;74(6):477-495.
doi: 10.3322/caac.21863. Epub 2024 Oct 1.

Breast cancer statistics 2024

Angela N Giaquinto  1 , Hyuna Sung  1 , Lisa A Newman  2 , Rachel A Freedman  3 , Robert A Smith  4 , Jessica Star  1 , Ahmedin Jemal  1 , Rebecca L Siegel  1
Affiliations
Free article

Breast cancer statistics 2024

Angela N Giaquinto et al. CA Cancer J Clin. 2024 Nov-Dec.
Free article

Abstract

This is the American Cancer Society's biennial update of statistics on breast cancer among women based on high-quality incidence and mortality data from the National Cancer Institute and the Centers for Disease Control and Prevention. Breast cancer incidence continued an upward trend, rising by 1% annually during 2012-2021, largely confined to localized-stage and hormone receptor-positive disease. A steeper increase in women younger than 50 years (1.4% annually) versus 50 years and older (0.7%) overall was only significant among White women. Asian American/Pacific Islander women had the fastest increase in both age groups (2.7% and 2.5% per year, respectively); consequently, young Asian American/Pacific Islander women had the second lowest rate in 2000 (57.4 per 100,000) but the highest rate in 2021 (86.3 per 100,000) alongside White women (86.4 per 100,000), surpassing Black women (81.5 per 100,000). In contrast, the overall breast cancer death rate continuously declined during 1989-2022 by 44% overall, translating to 517,900 fewer breast cancer deaths during this time. However, not all women have experienced this progress; mortality remained unchanged since 1990 in American Indian/Alaska Native women, and Black women have 38% higher mortality than White women despite 5% lower incidence. Although the Black-White disparity partly reflects more triple-negative cancers, Black women have the lowest survival for every breast cancer subtype and stage except localized disease, with which they are 10% less likely to be diagnosed than White women (58% vs. 68%), highlighting disadvantages in social determinants of health. Progress against breast cancer could be accelerated by mitigating racial, ethnic, and social disparities through improved clinical trial representation and access to high-quality screening and treatment.

Keywords: breast cancer; breast neoplasms; epidemiology; health disparities; incidence; molecular subtype; mortality.

PubMed Disclaimer

Similar articles

  • Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.
    DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. DeSantis CE, et al. CA Cancer J Clin. 2016 Jan-Feb;66(1):31-42. doi: 10.3322/caac.21320. Epub 2015 Oct 29. CA Cancer J Clin. 2016. PMID: 26513636
  • Breast Cancer Statistics, 2022.
    Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, Jemal A, Siegel RL. Giaquinto AN, et al. CA Cancer J Clin. 2022 Nov;72(6):524-541. doi: 10.3322/caac.21754. Epub 2022 Oct 3. CA Cancer J Clin. 2022. PMID: 36190501
  • Breast cancer statistics, 2019.
    DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL. DeSantis CE, et al. CA Cancer J Clin. 2019 Nov;69(6):438-451. doi: 10.3322/caac.21583. Epub 2019 Oct 2. CA Cancer J Clin. 2019. PMID: 31577379
  • Breast cancer statistics, 2013.
    DeSantis C, Ma J, Bryan L, Jemal A. DeSantis C, et al. CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62. doi: 10.3322/caac.21203. Epub 2013 Oct 1. CA Cancer J Clin. 2014. PMID: 24114568 Review.
  • Socioeconomic factors and breast carcinoma in multicultural women.
    Baquet CR, Commiskey P. Baquet CR, et al. Cancer. 2000 Mar 1;88(5 Suppl):1256-64. doi: 10.1002/(sici)1097-0142(20000301)88:5+<1256::aid-cncr13>3.0.co;2-3. Cancer. 2000. PMID: 10705364 Review.
See all similar articles

Cited by

References

REFERENCES

    1. Teglia F, Angelini M, Astolfi L, Casolari G, Boffetta P. Global association of COVID‐19 pandemic measures with cancer screening: a systematic review and meta‐analysis. JAMA Oncol. 2022;8(9):1287‐1293. doi:10.1001/jamaoncol.2022.2617
    1. Star J, Bandi P, Siegel RL, et al. Cancer screening in the United States during the second year of the COVID‐19 pandemic. J Clin Oncol. 2023;41(27):4352‐4359. doi:10.1200/jco.22.02170
    1. Richman I, Tessier‐Sherman B, Galusha D, Oladele CR, Wang K. Breast cancer screening during the COVID‐19 pandemic: moving from disparities to health equity. J Natl Cancer Inst. 2023;115(2):139‐145. doi:10.1093/jnci/djac172
    1. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence Data—Cancer in North America (CiNA) Research Data. 1995–2021, Standard File, American Cancer Society Facts and Figures (which includes data from the Centers for Disease Control and Prevention's National Program of Cancer Registries, the Canadian Cancer Registry's Provincial and Territorial Registries, and the National Cancer Institute's SEER Registries), certified by the NAACCR as meeting high‐quality incidence data standards for the specified time periods; National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2023.
    1. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence Data—Cancer in North America (CiNA) Research Data. 1998–2021, Delay Adjusted Factors—American Cancer Society Facts and Figures (which includes data from the Centers for Disease Control and Prevention's National Program of Cancer Registries, the Canadian Cancer Registry's Provincial and Territorial Registries, and the National Cancer Institute's SEER Registries), certified by the NAACCR as meeting high‐quality incidence data standards for the specified time periods. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2023.

LinkOut - more resources